Financial Ratios | Torrent Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE1544.05-3.6 (-0.23 %)
PREV CLOSE (Rs.) 1547.65
OPEN PRICE (Rs.) 1550.00
BID PRICE (QTY) 1539.10 (15)
OFFER PRICE (QTY) 1541.40 (15)
VOLUME 357
TODAY'S LOW / HIGH (Rs.)1544.05 1555.30
52 WK LOW / HIGH (Rs.)1242.5 1722.7
NSE1542.25-5.65 (-0.37 %)
PREV CLOSE( Rs. ) 1547.90
OPEN PRICE (Rs.) 1556.00
BID PRICE (QTY) 1542.00 (48)
OFFER PRICE (QTY) 1542.25 (30)
VOLUME 13165
TODAY'S LOW / HIGH(Rs.) 1540.05 1559.40
52 WK LOW / HIGH (Rs.)1242.08 1750

Financial Ratios

Select year
ParticularsMar2022Mar2021Mar2020Mar2019Mar2018
Operational & Financial Ratios
   Earnings Per Share (Rs)45.9273.9760.5525.7840.07
   CEPS(Rs)42.5256.4249.6131.1432.11
   DPS(Rs)48.0035.0032.0017.0014.00
   Book NAV/Share(Rs)351.75344.90284.99279.15273.11
   Tax Rate(%)36.6017.9813.6422.3227.16
Margin Ratios
   Core EBITDA Margin(%)15.9816.6714.5113.6111.91
   EBIT Margin(%)9.7412.6310.957.3311.01
   Pre Tax Margin(%)8.0610.267.943.878.27
   PAT Margin (%)5.118.416.853.006.02
   Cash Profit Margin (%)9.4612.8411.237.269.65
Performance Ratios
   ROA(%)5.929.207.503.155.81
   ROE(%)13.1823.4921.479.3415.12
   ROCE(%)14.3517.6215.289.7513.81
   Asset Turnover(x)1.161.091.091.050.96
   Sales/Fixed Asset(x)1.431.431.481.501.57
   Working Capital/Sales(x)17.2923.56-31.60-113.69186.85
Efficiency Ratios
   Fixed Capital/Sales(x)0.700.700.680.670.64
   Receivable days37.8638.9237.6533.7835.74
   Inventory Days61.7159.2449.8449.0157.16
   Payable days306.08383.19381.76370.58451.45
Valuation Parameters
   PER(x)30.4517.1816.2837.8631.14
   PCE(x)32.8822.5219.8731.3519.43
   Price/Book(x)7.957.376.926.994.57
   Yield(%)1.721.381.620.871.12
   EV/Net Sales(x)5.995.904.854.994.49
   EV/Core EBITDA(x)19.3818.6216.8218.7516.21
   EV/EBIT(x)34.4025.1323.5435.9121.55
   EV/CE(x)4.043.462.842.781.91
   M Cap / Sales5.565.374.204.313.55
Growth Ratio
   Net Sales Growth(%)6.290.823.4728.962.31
   Core EBITDA Growth(%)3.5810.7112.3323.792.97
   EBIT Growth(%)-21.1914.7853.68-14.04-4.19
   PAT Growth(%)-37.9222.17134.86-35.66-27.36
   EPS Growth(%)-37.9222.17134.88-35.66-27.36
Financial Stability Ratios
   Total Debt/Equity(x)0.680.831.211.281.40
   Current Ratio(x)1.201.130.910.981.01
   Quick Ratio(x)0.650.590.520.600.64
   Interest Cover(x)5.815.323.632.114.02
   Total Debt/Mcap(x)0.080.110.180.180.31